Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
Active, not recruiting · NCT04566887 · Registry updated 2026-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-06-12 | NCT04566887 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Health Network, Toronto | 417 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer Agency | Vancouver | Canada | 9 |
| Centre Hospitalier Universitaire de Québec | Québec | Canada | 1 |
| Princess Margaret Cancer Centre | Toronto | Canada | 22 |
| QEII Health Sciences Centre | Halifax | Canada | 7 |
| Sunnybrook Research Institute | Toronto | Canada | 6 |